Cargando…
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials
BACKGROUND: Cost-effectiveness analyses embedded within randomized trials allow for evaluation of value alongside conventional efficacy outcomes; however, collection of resource utilization data can require considerable trial resources. METHODS: We re-analyzed the results from four phase III Canadia...
Autores principales: | Cheung, Matthew C, Chan, Kelvin KW, Golden, Shane, Hay, Annette, Pater, Joseph, Prica, Anca, Chen, Bingshu E, Leighl, Natasha, Mittmann, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290988/ https://www.ncbi.nlm.nih.gov/pubmed/33866856 http://dx.doi.org/10.1177/17407745211005045 |
Ejemplares similares
-
Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial
por: Hoch, Jeffrey S., et al.
Publicado: (2019) -
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
por: Prica, Anca, et al.
Publicado: (2021) -
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
por: Everest, Louis, et al.
Publicado: (2023) -
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data
por: Hay, Annette E, et al.
Publicado: (2021) -
The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group
por: Chan, Kelvin K. W., et al.
Publicado: (2021)